Skip to main content
. 2023 Jan 12;11(1):200. doi: 10.3390/biomedicines11010200

Figure 4.

Figure 4

GLYATL-1 expression in normal breast duct, breast carcinoma in situ, and invasive breast carcinoma tissues. GLYATL-1 expression in (A,B) normal breast duct tissues. (C,D) Breast carcinoma in situ. (E,F) Invasive breast carcinoma tissues. (A,C,E) ×20 μm. (B,D,F) ×40 μm.